Ignite Creation Date:
2024-05-06 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03638427
Status:
COMPLETED
Last Update Posted:
2024-05-28
First Post:
2018-08-16
Brief Title:
Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the feasibility and efficacy of assessing HR-HPV DNA and HPV E6E7 mRNA via self-collected menstrual blood in a smart menstrual pad In other words can the investigators detect the high risk strains of the human papilloma virus HPV that are associated with cervical cancer in self-collected menstrual blood as an alternative to collecting vaginal swabs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GYNCVX0005 | OTHER | Stanford OnCore | None |
| NCI-2020-04139 | REGISTRY | None | None |